Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00387725
Status:
COMPLETED
Last Update Posted:
2014-11-21
First Post:
2006-10-11
Brief Title:
Study Evaluating Safety Immunogenicity of rLP2086 Vaccine in Adolescents
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Randomized Observer-blinded Parallel-group Active-control Phase ½ Trial Of The Safety Immunogenicity And Tolerability Of 20 Mg 60 Mg And 200 Mg Of Meningococcal Group B Rlp2086 Vaccine In Healthy Children And Adolescents Aged 8 To 14 Years
Status:
COMPLETED
Status Verified Date:
2014-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study to evaluate the safety of an investigational meningitis vaccine and the immune response to it in adolescents
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| B1971006 | OTHER | Alias Study Number | None |